Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
0.4 AUD | +17.65% | +321.05% | -39.39% |
Apr. 23 | Australian Shares Rise on Business Activity Growth; Osteopore Soars 127% | MT |
Apr. 23 | Osteopore Commences In-Human Clinical Trials for Knee Preservation; Shares Surge 194% | MT |
Sales 2022 | 1.69M 1.24M 1.9M | Sales 2023 | 2.22M 1.63M 2.49M | Capitalization | 6.82M 5.01M 7.66M |
---|---|---|---|---|---|
Net income 2022 | -4M -2.94M -4.49M | Net income 2023 | -4M -2.94M -4.49M | EV / Sales 2022 | 9.64 x |
Net cash position 2022 | 1.27M 936K 1.43M | Net cash position 2023 | 64.06K 47.09K 71.97K | EV / Sales 2023 | 3.05 x |
P/E ratio 2022 |
-4.42
x | P/E ratio 2023 |
-1.29
x | Employees | - |
Yield 2022 * |
-
| Yield 2023 |
-
| Free-Float | 96.4% |
1 day | +17.65% | ||
1 week | +321.05% | ||
Current month | +33.33% | ||
1 month | +515.38% | ||
3 months | -23.81% | ||
6 months | -47.71% | ||
Current year | -39.39% |
Managers | Title | Age | Since |
---|---|---|---|
Yu Jing Lim
CEO | Chief Executive Officer | - | 14-11-30 |
Ning Voon Shu
AUD | Comptroller/Controller/Auditor | - | - |
Kellie Davis
SEC | Corporate Secretary | - | 23-01-25 |
Members of the board | Title | Age | Since |
---|---|---|---|
Kei Wei Leong
CHM | Chairman | 49 | 21-07-31 |
Michael Keenan
BRD | Director/Board Member | - | 23-07-17 |
Swee Hin Teoh
BRD | Director/Board Member | - | 19-06-23 |
Date | Price | Change | Volume |
---|---|---|---|
24-04-26 | 0.4 | +17.65% | 761 018 |
24-04-24 | 0.34 | -13.92% | 515,524 |
24-04-23 | 0.395 | +139.39% | 2,358,355 |
24-04-22 | 0.165 | +73.68% | 253,205 |
24-04-19 | 0.095 | -20.83% | 164,089 |
Delayed Quote Australian S.E., April 26, 2024 at 02:10 am EDT
More quotes1st Jan change | Capi. | |
---|---|---|
-39.39% | 2.28M | |
-2.92% | 185B | |
-3.80% | 105B | |
-5.48% | 66.59B | |
+11.22% | 54.66B | |
+16.74% | 47.78B | |
+4.06% | 41.26B | |
+4.56% | 26.95B | |
+1.64% | 26.37B | |
+12.96% | 24.8B |
- Stock Market
- Equities
- OSX Stock